InvestorsHub Logo
Followers 1
Posts 287
Boards Moderated 0
Alias Born 11/05/2013

Re: None

Sunday, 10/04/2020 7:26:18 AM

Sunday, October 04, 2020 7:26:18 AM

Post# of 32923
The acquisition of RespRx is an all stock deal. PAOG has purchased RexpRx from KALY for common stock. PAOG remains in negotiations with KALY about a potential comprehensive acquisition of the underlying patent from which the RespRx formula was derived.

Has anyone received shares of PAOG yet?
Has anyone been informed of the new direction/business KALY announced after selling off respRx

Shareholders seemed to have been left wondering???